Inspire Medical Systems, Inc.
NYSE:INSPMedical - Devices
+$0.51 today
- Market cap
- $1.68B
- Beta
- 0.73
- P/E (TTM)
- 9.1
- EPS (TTM)
- $4.57
Volume 0.51M
Average 1.13M
INSP Total Debt
Short-term and long-term borrowings combined.
Inspire Medical Systems, Inc.NYSE: INSP
Total Debt · Q2 FY2026 · quarter ended Jun 2026
Total debt falls 12.0% from a year ago
Total debt stood at $29.09M at the end of Q2 FY2026, down 12.0% from a year earlier and down 1.6% from the prior quarter. Over 3 fiscal years it compounded at +25.1% a year.
Context
- Total debt amounted to 3.1% of total assets at the end of Q2 FY2026, down 1.0 pp from a year earlier.
- Total debt increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -12.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 32.16M USD
- Year-over-year change
- +1.1%
- 4-year CAGR
- -1.5%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.16M | +1.1% |
| FY2024 | 2024-12-31 | 31.79M | +28.0% |
| FY2023 | 2023-12-31 | 24.85M | +51.4% |
| FY2022 | 2022-12-31 | 16.41M | -51.9% |
| FY2021 | 2021-12-31 | 34.1M | — |
Total Debt vs competitors
How INSP compares with its peers on the latest reported figures
- INSP's Jun 2026 total debt of $29.09M is the lowest of the 9 companies compared; the peer median is $223.99M.
- Its year-over-year change of -12.0% is the 5th highest of 9, against a peer median of -14.2%.
- Total debt amounts to 3.1% of total assets for INSP, versus a peer median of 25.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ARDTArdent Health Partners, LLC | Mar 2026 | $2.29B | +0.4% | -1.8% | 43.5% |
| Jul 2026 | $1.36B | +3.3% | +11.5% | 39.9% | |
| Sep 2026 | $1.24B | -77.5% | +10.8% | 20.9% | |
| Mar 2026 | $258.16M | -28.8% | -6.5% | 29.2% | |
| Mar 2026 | $189.82M | +2.4% | +123.6% | 30.2% | |
| Jun 2026 | $114M | +4.6% | -2.3% | 12.3% | |
| Jun 2026 | $108.82M | -51.0% | +5.4% | 7.5% | |
| Mar 2026 | $51.66M | -35.3% | -12.6% | 10.6% | |
| Jun 2026 | $29.09M | -12.0% | +25.1% | 3.1% | |
| Peer median (excluding INSP) | $223.99M | -14.2% | +1.8% | 25.0% | |
Competitors are the stored peer set for INSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 214.47M | 441.59M | 185.54M | 150.15M | 104.81M |
| Short-term Investments | 0 | 9.82M | 274.84M | 295.4M | 203.46M |
| Net Receivables | 34.18M | 61.23M | 89.88M | 93.07M | 119.69M |
| Inventory | 17.23M | 11.89M | 33.89M | 80.12M | 145.29M |
| Other Current Assets | 0 | 5.51M | 9.6M | 12.07M | 10.4M |
| Total Current Assets | 268.54M | 530.03M | 593.74M | 630.81M | 583.65M |
| Property, Plant & Equipment (Net) | 16.41M | 24.13M | 62.65M | 95.24M | 121.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 9.94M | 10.5M | 9.14M | 71M | 96.33M |
| Tax Assets | 0 | 0 | 0 | 0 | 88.67M |
| Other Non-current Assets | 204K | 215K | 11.28M | 11.34M | 17.26M |
| Total Non-current Assets | 26.55M | 34.84M | 83.07M | 177.58M | 323.66M |
| Total Assets | 295.08M | 564.88M | 676.81M | 808.38M | 907.32M |
| Account Payables | 11.67M | 26.85M | 38.84M | 38.69M | 36.57M |
| Short-term Debt | 9.19M | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 577K | 1.61M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 8.41M |
| Total Current Liabilities | 41.31M | 61.19M | 78.11M | 88.5M | 96.06M |
| Long-term Debt | 15.8M | 7.54M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 134K | (7.39M) | 1.35M | 148K | 104K |
| Total Non-current Liabilities | 24.73M | 7.68M | 26.19M | 30.19M | 30.1M |
| Total Liabilities | 66.04M | 68.87M | 104.3M | 118.69M | 126.16M |
| Common Stock | 27K | 29K | 30K | 30K | 29K |
| Retained Earnings | (279.39M) | (324.27M) | (345.42M) | (291.91M) | (146.49M) |
| Accumulated OCI | (55K) | (86K) | 800K | 536K | 464K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 229.05M | 496.01M | 572.51M | 689.7M | 781.16M |
| Total Debt | 34.1M | 16.41M | 24.85M | 31.79M | 32.16M |
| Net Debt | (180.37M) | (425.18M) | (160.69M) | (118.36M) | (72.66M) |
Inspire Medical Systems, Inc.
NYSE:INSP
Intrinsic Alpha fair value
Locked
Current Price
$58.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.